Cumulative live birth rate of low prognosis patients with POSEIDON stratification: a single-centre data analysis

Rui Yang,Chunmei Zhang,Lixue Chen,Yuanyuan Wang,Rong Li,Ping Liu,Jie Qiao
DOI: https://doi.org/10.1016/j.rbmo.2020.08.003
IF: 4.567
2020-11-01
Reproductive BioMedicine Online
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Research question</h3><p>Does POSEIDON classification helps stratify the reproductive potential of patients with low prognosis more effectively from the perspective of prognosis; and since cumulative live birth rate (CLBR) is an effect indication, how is CLBR in patients stratified using POSEIDON?</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Design</h3><p>This was a retrospective cohort study of 10615 women who underwent <em>in vitro</em> fertilization (IVF) treatment at the Peking University Third Hospital between January 2017 and December 2017. The patients were stratified according to POSEIDON criteria. The clinical characteristics, fresh embryo transfer outcomes and CLBR during the first two ovarian stimulation cycles was recorded.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Gonadotropin-releasing hormone antagonist protocol was the most commonly used treatment in both ovarian stimulation cycles. After the failure of the first IVF treatment, 2063 (29.2%) women continued the second treatment, and 10.9% of them switched to the micro-stimulation protocol. Compared with non-POSEIDON group, the CLBR of the first cycle in each POSEIDON group was lower (P&lt;0.001). The CLBRs of the second cycle in older patients (POSEIDON groups 2b and 4) and in younger patients with poor ovarian reserve (POSEIDON group 3) were lower than that in non-POSEIDON group (P&lt;0.05). Subgroup analysis showed that younger patients had higher CLBR than older patients in both cycles (P&lt;0.05).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>The CLBRs vary among different POSEIDON groups. The results may help reproductive physicians better understanding the characteristics of low prognosis patients and developing individualized treatment plan.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">KEY MESSAGE</h3><p>POSEIDON classification helps stratify the reproductive potential of patients with low prognosis more effectively from the perspective of prognosis. Cumulative live birth rate varies among different POSEIDON groups. Development of individualized treatment according to POSEIDON groups will improve clinical outcomes of low prognosis patients.</p>
obstetrics & gynecology,reproductive biology
What problem does this paper attempt to address?